Evidence map›Paper›PMID 35183217›Full record

ArticleHealth research policy and systems2022

Future health spending forecast in leading emerging BRICS markets in 2030: health policy implications.

Mihajlo Jakovljevic, Demetrios Lamnisos, Ronny Westerman, Vijay Kumar Chattu, Arcadio Cerda

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Health research policy and systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
25.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Health technology assessment for digital health Technologies in India: a framework for action.International journal of technology assessment in health care · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 8 countries.

Mihajlo JakovljevicInstitute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St Petersburg, Russia. sidartagothama@gmail.com.ORCID http://orcid.org/0000-0002-9160-6846
Demetrios LamnisosDepartment of Health Sciences, European University Cyprus, Nicosia, Cyprus.
Ronny WestermanFederal Institute for Population Research, Wiesbaden, Germany.
Vijay Kumar ChattuDepartment of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, M5G 2C4, Canada.
Arcadio CerdaFaculty of Economics and Business, University of Talca, Talca, Chile.
European University Cyprus · CYFederal Institute for Population Research · DEUniversity of Kragujevac · RSUniversity of Talca · CLUniversity of Toronto · CA

Funding

ministarstvo prosvete, nauke i tehnološkog razvoja OI175014The Science Fund of the Republic of Serbia Em-CEAS
6 · The paper itself

Abstract

backgroundThe leading emerging markets of Brazil, Russia, India, China and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. BRICS' share of global health spending and future projections will play a prominent role during the 2020s. The purpose of the current research was to examine the decades-long underlying historical trends in BRICS countries' health spending and explore these data as the grounds for reliable forecasting of their health expenditures up to 2030.

methodsBRICS' health spending data spanning 1995-2017 were extracted from the Institute for Health Metrics and Evaluation (IHME) Financing Global Health 2019 database. Total health expenditure, government, prepaid private and out-of-pocket spending per capita and gross domestic product (GDP) share of total health spending were forecasted for 2018-2030. Autoregressive integrated moving average (ARIMA) models were used to obtain future projections based on time series analysis.

resultsPer capita health spending in 2030 is projected to be as follows: Brazil, $1767 (95% prediction interval [PI] 1615, 1977); Russia, $1933 (95% PI 1549, 2317); India, $468 (95% PI 400.4, 535); China, $1707 (95% PI 1079, 2334); South Africa, $1379 (95% PI 755, 2004). Health spending as a percentage of GDP in 2030 is projected as follows: Brazil, 8.4% (95% PI 7.5, 9.4); Russia, 5.2% (95% PI 4.5, 5.9); India, 3.5% (95% PI 2.9%, 4.1%); China, 5.9% (95% PI 4.9, 7.0); South Africa, 10.4% (95% PI 5.5, 15.3).

conclusionsAll BRICS countries show a long-term trend towards increasing their per capita spending in terms of purchasing power parity (PPP). India and Russia are highly likely to maintain stable total health spending as a percentage of GDP until 2030. China, as a major driver of global economic growth, will be able to significantly expand its investment in the health sector across an array of indicators. Brazil is the only large nation whose health expenditure as a percentage of GDP is about to contract substantially during the third decade of the twenty-first century. The steepest curve of increased per capita spending until 2030 seems to be attributable to India, while Russia should achieve the highest values in absolute terms. Health policy implications of long-term trends in health spending indicate the need for health technology assessment dissemination among the BRICS ministries of health and national health insurance funds. Matters of cost-effective allocation of limited resources will remain a core challenge in 2030 as well.

Indexed as

Healthcare FinancingHealth ExpendituresBrazilChinaHealth PolicyHumansIndiaSouth Africa2030BrazilBRICSChinaForecastHealth expenditureHealth financingHealth policyIndiaProjectionsRussiaSouth AfricaSpendingSustainable Development GoalsUN

Identifiers

PMID35183217
PMCPMC8857747
OpenAlexW4225354195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.